Global Transcatheter Treatment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Transcatheter Treatment is used for the treatment of heart disorders it includes Transfemoral, Transapical, and Transaortic Procedures. It uses a catheter to place an aortic valve in the heart. A small opening in artery on the front of the chest is made and then thread the catheter and new valve into the right position. In this treatment there is no need to open the chest during the procedure. The Transcatheter Treatment market is expanding because of rising demand for minimally invasive procedure and growing incidences of chronic disorders.
According to the Organization for Economic Co-Operation and Development (OECD) in 2020, the adoption of minimally invasive procedures is increasing rapidly all over the World. It includes Australia, Austria, Belgium and Canada, etc. In Australia, the number of minimal invasive surgeries was about 51219 in the year 2017. Whereas it is reached 57174 by 2019. In 2017, the number of surgical procedures in Austria was about 116739. Whereas, by 2019 it is reached 122726. Rising geriatric population and technological advancement across the medical sector creates lucrative opportunities for the market growth. However, higher treatment cost hampers the market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Transcatheter Treatment Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominates the market with highest revenue, owing to the growing geriatric population, rising technological advancement across the medical sector and rising number of transcatheter valve replacement procedures. Asia Pacific is expected to grow lucrative during the forecast period, owing to factors such as increasing incidences of cardiovascular diseases, rising adoption of minimal invasive surgeries etc. in the forecast period
Major market players included in this report are:
Edwards Lifesciences Corporation.
Boston Scientific Corporation;
JenaValve Technology, Inc.;
Meril Lifesciences Pvt. Ltd.
Recent Developments in the Market:
In August 2022 - Edwards Lifesciences Corporation announced that its PASCAL Precision transcatheter valve repair system has received CE Mark for the treatment of mitral and tricuspid regurgitation (MR and TR).
Global Transcatheter Treatment Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Types, Procedure, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
Rest of the World